{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:50:11Z","timestamp":1782100211071,"version":"3.54.5"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20480"],"award-info":[{"award-number":["U21A20480"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04268-9","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:14:43Z","timestamp":1777544083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Revolutionizing lung cancer screening: the rise of artificial intelligence integrating circulating tumor markers"],"prefix":"10.1186","volume":"24","author":[{"given":"Honghai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoning","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"9","key":"4268_CR1","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20(9):624\u201339.","journal-title":"Nat Rev Clin Oncol"},{"key":"4268_CR2","doi-asserted-by":"crossref","unstructured":"Wolf AMD, Oeffinger KC, Shih TY, et al. Screening for lung cancer: 2023 guideline update from the American Cancer Society. CA Cancer J Clin. 2024;74(1):50\u201381.","DOI":"10.3322\/caac.21811"},{"issue":"6","key":"4268_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","volume":"382","author":"HJ de Koning","year":"2020","unstructured":"de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503\u201313.","journal-title":"N Engl J Med"},{"issue":"10","key":"4268_CR4","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.jtho.2019.05.044","volume":"14","author":"National Lung Screening Trial Research T","year":"2019","unstructured":"National Lung Screening Trial Research T. Lung cancer incidence and mortality with extended follow-up in the National Lung Screening Trial. J Thorac Oncol. 2019;14(10):1732\u201342.","journal-title":"J Thorac Oncol"},{"issue":"8","key":"4268_CR5","first-page":"CD013829","volume":"8","author":"A Bonney","year":"2022","unstructured":"Bonney A, Malouf R, Marchal C, Manners D, Fong KM, Marshall HM, Irving LB, Manser R. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality. Cochrane Database Syst Rev. 2022;8(8):CD013829.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"4268_CR6","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jama.2021.0377","volume":"325","author":"DE Jonas","year":"2021","unstructured":"Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, et al. Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US preventive services task force. JAMA. 2021;325(10):971\u201387.","journal-title":"JAMA"},{"issue":"s1","key":"4268_CR7","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.3233\/TUB-230004","volume":"46","author":"D van den Broek","year":"2024","unstructured":"van den Broek D, Groen HJ. Screening approaches for lung cancer by blood-based biomarkers: challenges and opportunities. Tumor Biol. 2024;46(s1):S65\u201380.","journal-title":"Tumor Biol"},{"issue":"2","key":"4268_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41571-021-00560-7","volume":"19","author":"K Bera","year":"2021","unstructured":"Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2021;19(2):132\u201346.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"4268_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.annonc.2023.10.125","volume":"35","author":"A Prelaj","year":"2024","unstructured":"Prelaj A, Miskovic V, Zanitti M, et al. Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review. Ann Oncol. 2024;35(1):29\u201365.","journal-title":"Ann Oncol"},{"key":"4268_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.semcancer.2023.05.004","volume":"93","author":"M Chen","year":"2023","unstructured":"Chen M, Copley SJ, Viola P, Lu H, Aboagye EO. Radiomics and artificial intelligence for precision medicine in lung cancer treatment. Semin Cancer Biol. 2023;93:97\u2013113.","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"4268_CR11","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/annonc\/mdz117","volume":"30","author":"U Pastorino","year":"2019","unstructured":"Pastorino U, Silva M, Sestini S, Sabia F, Boeri M, Cantarutti A, Sverzellati N, Sozzi G, Corrao G, Marchian\u00f2 A. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019;30(7):1162\u20139.","journal-title":"Ann Oncol"},{"issue":"8","key":"4268_CR12","doi-asserted-by":"publisher","first-page":"e2330452","DOI":"10.1001\/jamanetworkopen.2023.30452","volume":"6","author":"MM Schapira","year":"2023","unstructured":"Schapira MM, Hubbard RA, Whittle J. Lung cancer screening decision aid designed for a primary care setting: a randomized clinical trial. JAMA Netw Open. 2023;6(8):e2330452.","journal-title":"JAMA Netw Open"},{"key":"4268_CR13","doi-asserted-by":"crossref","unstructured":"Yabroff KR, Mariotto A, Tangka F et al. Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated With CancerCare. Journal of the National Cancer Institute. 2021;113(12):1670\u201382.","DOI":"10.1093\/jnci\/djab192"},{"key":"4268_CR14","first-page":"2083121","volume":"26","author":"A Lilienfeld","year":"1966","unstructured":"Lilienfeld A, Archer PG, Burnett CH, et al. An evaluation of radiologic and cytologic screening for the early detection of lung cancer: a cooperative pilot study of the American Cancer Society and Veterans Administration. Cancer Res. 1966;26:2083121.","journal-title":"Cancer Res"},{"key":"4268_CR15","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1001\/jama.1971.03180390031007","volume":"216","author":"W Weiss","year":"1971","unstructured":"Weiss W, Boucot KR, Cooper DA. The Philadelphia pulmonary neoplasm research project. Survival factors in bronchogenic carcinoma. JAMA. 1971;216:2119\u201323.","journal-title":"JAMA"},{"key":"4268_CR16","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1001\/jama.2011.1591","volume":"306","author":"MM Oken","year":"2011","unstructured":"Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;306:1865\u201373.","journal-title":"JAMA"},{"key":"4268_CR17","doi-asserted-by":"publisher","first-page":"16170","DOI":"10.1136\/thoraxjnl-2015-207140","volume":"71","author":"JK Field","year":"2016","unstructured":"Field JK, Duffy SW, Baldwin DR, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax. 2016;71:16170.","journal-title":"Thorax"},{"key":"4268_CR18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1164\/rccm.201408-1475OC","volume":"191","author":"M Infante","year":"2015","unstructured":"Infante M, Cavuto S, Lutman FR, et al. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med. 2015;191:1166\u201375.","journal-title":"Am J Respir Crit Care Med"},{"key":"4268_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/thoraxjnl-2016-209825","volume":"72","author":"E Paci","year":"2017","unstructured":"Paci E, Puliti D, Lopes Pegna A, et al. Mortality, survival, and incidence rates in the ITALUNG randomized lung cancer screening trial. Thorax. 2017;72:825\u201331.","journal-title":"Thorax"},{"key":"4268_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1164\/rccm.201505-1040OC","volume":"193","author":"MM Wille","year":"2016","unstructured":"Wille MM, Dirksen A, Ashraf H, et al. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling. Am J Respir Crit Care Med. 2016;193:542\u201351.","journal-title":"Am J Respir Crit Care Med"},{"key":"4268_CR21","doi-asserted-by":"publisher","first-page":"150313","DOI":"10.1002\/ijc.32486","volume":"146","author":"N Becker","year":"2020","unstructured":"Becker N, Motsch E, Trotter A, et al. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial. Int J Cancer. 2020;146:150313.","journal-title":"Int J Cancer"},{"key":"4268_CR22","doi-asserted-by":"crossref","first-page":"86874","DOI":"10.1002\/ijc.22134","volume":"120","author":"CA van Iersel","year":"2007","unstructured":"van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer. 2007;120:86874.","journal-title":"Int J Cancer"},{"key":"4268_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"Aberle DR, Adams AM, Berg CD, et al. National Lung Screening Trial Research Team, Reduced Lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395\u2013409.","journal-title":"N Engl J Med"},{"key":"4268_CR24","unstructured":"Lung-Screening Reporting and Data System. (Lun-gRADS) version 2022. Available at: https:\/\/www.acr.org\/Clinical-Resources\/Reporting-and-Data-Systems\/Lung-Rads. Accessed 19 Jan 2023."},{"issue":"1","key":"4268_CR25","first-page":"19","volume":"191","author":"T Lynn","year":"2015","unstructured":"Lynn T, Tanoue, Nichole T, Tanner MK, Gould, Silvestri GA. Lung Cancer Screen Am J Respiratory Crit Care Med. 2015;191(1):19\u201333.","journal-title":"Lung Cancer Screen Am J Respiratory Crit Care Med"},{"issue":"4","key":"4268_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/MCP.0000000000000287","volume":"22","author":"LynnT.Tanoue","year":"2016","unstructured":"LynnT.Tanoue. .Lung cancer screening. Curr Opinionin Pulmonary Med. 2016;22(4):327\u201335.","journal-title":"Curr Opinionin Pulmonary Med"},{"issue":"4","key":"4268_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jinf.2023.07.006","volume":"87","author":"AA Theodosiou","year":"2023","unstructured":"Theodosiou AA, Read RC. Artificial intelligence, machine learning, and deep learning: potential resources for the infection clinician. J Infect. 2023;87(4):287\u201394.","journal-title":"J Infect"},{"key":"4268_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2022.102470","volume":"79","author":"BHM van der Velden","year":"2022","unstructured":"van der Velden BHM, Kuijf HJ, Gilhuijs KGA, Viergever MA. Explainable artificial intelligence (XAI) in deep learning-based medical image analysis. Med Image Anal. 2022;79:102470.","journal-title":"Med Image Anal"},{"key":"4268_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clinimag.2023.02.014","volume":"97","author":"PS Bobba","year":"2023","unstructured":"Bobba PS, Sailer A, Pruneski JA, Beck S, Mozayan A, Mozayan S, et al. Natural language processing in radiology: clinical applications and future directions. Clin Imaging. 2023;97:55\u201361.","journal-title":"Clin Imaging"},{"issue":"3","key":"4268_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1148\/radiol.220571","volume":"304","author":"M Yanagawa","year":"2022","unstructured":"Yanagawa M. Artificial intelligence improves radiologist performance for predicting malignancy at chest CT. Radiology. 2022;304(3):692\u20133.","journal-title":"Radiology"},{"key":"4268_CR31","doi-asserted-by":"publisher","unstructured":"de Margerie-Mellon C, Chassagnon G. Artificial intelligence: A critical review of applications for lung nodule and lung cancer. Diagn Interv Imaging. 2023;104(1):11\u201317. https:\/\/doi.org\/10.1016\/j.diii.2022.11.007.","DOI":"10.1016\/j.diii.2022.11.007"},{"issue":"12","key":"4268_CR32","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1515\/cclm-2022-0291","volume":"60","author":"Q Pei","year":"2022","unstructured":"Pei Q, Luo Y, Chen Y, Li J, Xie D, Ye T. Artificial intelligence in clinical applications for lung cancer: diagnosis, treatment, and prognosis. Clin Chem Lab Med. 2022;60(12):1974\u201383.","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"4268_CR33","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/RTI.0000000000000362","volume":"33","author":"J Cai","year":"2018","unstructured":"Cai J, Xu D, Liu S, Cham M. The added value of computer-aided detection of small pulmonary nodules and missed lung cancers. J Thorac Imaging. 2018;33(6):390\u20135.","journal-title":"J Thorac Imaging"},{"issue":"12","key":"4268_CR34","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S1470-2045(14)70387-0","volume":"15","author":"N Horeweg","year":"2014","unstructured":"Horeweg N, Scholten ET, de Jong PA, van der Aalst CM. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol. 2014;15(12):1342\u201350.","journal-title":"Lancet Oncol"},{"issue":"7","key":"4268_CR35","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1007\/s00330-020-06783-z","volume":"30","author":"S Chauvie","year":"2020","unstructured":"Chauvie S, De Maggi A, Baralis I, Dalmasso F, Berchialla P, Priotto R, et al. Artificial intelligence and radiomics enhance the positive predictive value of digital chest tomosynthesis for lung cancer detection within the SOS clinical trial. Eur Radiol. 2020;30(7):4134\u201340.","journal-title":"Eur Radiol"},{"key":"4268_CR36","first-page":"2864170","volume":"2022","author":"Y Chen","year":"2022","unstructured":"Chen Y, Tian X, Fan K, Zheng Y, Tian N, Fan K. The Value of Artificial Intelligence Film Reading System Based on Deep Learning in the Diagnosis of Non-Small-Cell Lung Cancer and the Significance of Efficacy Monitoring: A Retrospective, Clinical, Nonrandomized, Controlled Study. Comput Math Methods Med. 2022;2022:2864170.","journal-title":"Comput Math Methods Med"},{"issue":"2","key":"4268_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1148\/radiol.2021202818","volume":"299","author":"J Sung","year":"2021","unstructured":"Sung J, Park S, Lee SM, Bae W, Park B, Jung E, et al. Added value of deep learning-based detection system for multiple major findings on chest radiographs: a randomized crossover study. Radiology. 2021;299(2):450\u20139.","journal-title":"Radiology"},{"issue":"3","key":"4268_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/RTI.0000000000000613","volume":"37","author":"AF Abadia","year":"2022","unstructured":"Abadia AF, Yacoub B, Stringer N, Snoddy M, Kocher M, Schoepf UJ, et al. Diagnostic accuracy and performance of artificial intelligence in detecting lung nodules in patients with complex lung disease: a noninferiority study. J Thorac Imaging. 2022;37(3):154\u201361.","journal-title":"J Thorac Imaging"},{"issue":"3","key":"4268_CR39","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s00330-021-08268-z","volume":"32","author":"L Huang","year":"2022","unstructured":"Huang L, Lin W, Xie D, Yu Y, Cao H, Liao G, Wu S, Yao L, Wang Z, Wang M, Wang S, Wang G, Zhang D, Yao S, He Z, Cho WC, Chen D, Zhang Z, Li W, Qiao G, Chan LW, Zhou H. Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning approach, multicenter, diagnostic study. Eur Radiol. 2022;32(3):1983\u201396.","journal-title":"Eur Radiol"},{"issue":"9","key":"4268_CR40","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.3390\/s18092845","volume":"18","author":"CH Huang","year":"2018","unstructured":"Huang CH, Zeng C, Wang YC, Peng HY, Lin CS, Chang CJ, Yang HY. A Study of Diagnostic Accuracy Using a Chemical Sensor Array and a Machine Learning Technique to Detect Lung Cancer. Sens (Basel). 2018;18(9):2845.","journal-title":"Sens (Basel)"},{"issue":"1","key":"4268_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00330-021-08162-8","volume":"32","author":"JG Nam","year":"2022","unstructured":"Nam JG, Kim HJ, Lee EH, Hong W, Park J, Hwang EJ, Park CM, Goo JM. Value of a deep learning-based algorithm for detecting Lung-RADS category 4 nodules on chest radiographs in a health checkup population: estimation of the sample size for a randomized controlled trial. Eur Radiol. 2022;32(1):213\u201322.","journal-title":"Eur Radiol"},{"issue":"10","key":"4268_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.08.655","volume":"16","author":"N Wu","year":"2021","unstructured":"Wu N, Li X, Luo X. P62.10 AI-based three-dimension reconstruction for pulmonary nodules -new auxiliary exploration for thoracic surgery. J Thorac Oncol. 2021;16(10):S1181.","journal-title":"J Thorac Oncol"},{"issue":"5","key":"4268_CR43","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1007\/s00330-022-09317-x","volume":"33","author":"Y Ding","year":"2023","unstructured":"Ding Y, Zhang J, Zhuang W, Gao Z, Kuang K, Tian D, Deng C, Wu H, Chen R, Lu G, Chen G, Mendogni P, Migliore M, Kang MW, Kanzaki R, Tang Y, Yang J, Shi Q, Qiao G. Improving the efficiency of identifying malignant pulmonary nodules before surgery via a combination of artificial intelligence CT image recognition and serum autoantibodies. Eur Radiol. 2023;33(5):3092\u2013102.","journal-title":"Eur Radiol"},{"issue":"1","key":"4268_CR44","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1186\/s12885-022-10224-z","volume":"22","author":"R Zhang","year":"2022","unstructured":"Zhang R, Wei Y, Shi F, Ren J, Zhou Q, Li W, Chen B. The diagnostic and prognostic value of radiomics and deep learning technologies for patients with solid pulmonary nodules in chest CT images. BMC Cancer. 2022;22(1):1118.","journal-title":"BMC Cancer"},{"key":"4268_CR45","doi-asserted-by":"publisher","first-page":"e14559","DOI":"10.7717\/peerj.14559","volume":"11","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang S, Deng Z, Li Y, Yang Y, Huang H. Computed tomography-based radiomics machine learning models for prediction of histological invasiveness with sub-centimeter subsolid pulmonary nodules: a retrospective study. PeerJ. 2023;11:e14559.","journal-title":"PeerJ"},{"issue":"6","key":"4268_CR46","first-page":"573","volume":"60","author":"K Zhang","year":"2022","unstructured":"Zhang K, Wei ZH, Wang X, Chen KZ. [The diagnostic value of machine-learning-based models for predicting the malignancy of solid nodules in multiple pulmonary nodules]. Zhonghua Wai Ke Za Zhi. 2022;60(6):573\u20139.","journal-title":"Zhonghua Wai Ke Za Zhi"},{"issue":"2","key":"4268_CR47","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221894","volume":"307","author":"JG Nam","year":"2023","unstructured":"Nam JG, Hwang EJ, Kim J, Park N, Lee EH, Kim HJ, et al. AI improves nodule detection on chest radiographs in a health screening population: a randomized controlled trial. Radiology. 2023;307(2):e221894.","journal-title":"Radiology"},{"issue":"3","key":"4268_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11604-022-01359-x","volume":"41","author":"G Chassagnon","year":"2023","unstructured":"Chassagnon G, De Margerie-Mellon C, Vakalopoulou M, Marini R, Hoang-Thi TN, Revel MP, et al. Artificial intelligence in lung cancer: current applications and perspectives. Jpn J Radiol. 2023;41(3):235\u201344.","journal-title":"Jpn J Radiol"},{"issue":"15","key":"4268_CR49","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1158\/1078-0432.CCR-21-3044","volume":"28","author":"L Xia","year":"2022","unstructured":"Xia L, Mei J, Kang R, Deng S, et al. Perioperative ctDNA-Based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1). Clin Cancer Res. 2022;28(15):3308\u201317.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4268_CR50","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/annonc\/mdw619","volume":"28","author":"IS Batth","year":"2017","unstructured":"Batth IS, Mitra A, Manier S, Ghobrial IM, Menter D, Kopetz S, Li S. Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine. Ann Oncol. 2017;28(3):468\u201377.","journal-title":"Ann Oncol"},{"issue":"1","key":"4268_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-022-01543-7","volume":"21","author":"SN Lone","year":"2022","unstructured":"Lone SN, Nisar S, Masoodi T, Singh M, Rizwan A, Hashem S, El-Rifai W, Bedognetti D, Batra SK, Haris M, Bhat AA, Macha MA. Liquid biopsy: a step closer to transforming diagnosis, prognosis, and future of cancer treatments. Mol Cancer. 2022;21(1):79.","journal-title":"Mol Cancer"},{"issue":"10","key":"4268_CR52","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/cells8101195","volume":"8","author":"OA Sindeeva","year":"2019","unstructured":"Sindeeva OA, Verkhovskii RA, Sarimollaoglu M, Afanaseva GA, Fedonnikov AS, Osintsev EY, Kurochkina EN, Gorin DA, Deyev SM, Zharov VP, Galanzha EI. New Frontiers in Diagnosis and Therapy of Circulating Tumor Markers in Cerebrospinal Fluid In Vitro and In Vivo. Cells. 2019;8(10):1195.","journal-title":"Cells"},{"issue":"13","key":"4268_CR53","doi-asserted-by":"publisher","first-page":"7222","DOI":"10.3390\/ijms23137222","volume":"23","author":"M de Scordilli","year":"2022","unstructured":"de Scordilli M, Michelotti A, Bertoli E, De Carlo E, Del Conte A, Bearz A. Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials. Int J Mol Sci. 2022;23(13):7222.","journal-title":"Int J Mol Sci"},{"issue":"25","key":"4268_CR54","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1200\/JCO.21.02660","volume":"40","author":"M Provencio","year":"2022","unstructured":"Provencio M, Serna-Blasco R, Nadal E, et al. Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial). J Clin Oncol. 2022;40(25):2924\u201333.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4268_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00280-018-3586-8","volume":"82","author":"C Huang","year":"2018","unstructured":"Huang C, Liu S, Tong X, Fan H. Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications. Cancer Chemother Pharmacol. 2018;82(2):171\u201383.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"4268_CR56","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccell.2024.01.001","volume":"42","author":"S Heeke","year":"2024","unstructured":"Heeke S, Gay CM, Estecio MR, et al. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes. Cancer Cell. 2024;42(2):225\u2013e2375.","journal-title":"Cancer Cell"},{"issue":"6","key":"4268_CR57","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1200\/JCO.21.01929","volume":"40","author":"B Pellini","year":"2022","unstructured":"Pellini B, Chaudhuri AA. Circulating tumor DNA minimal residual disease detection of non-small-cell lung cancer treated with curative intent. J Clin Oncol. 2022;40(6):567\u201375.","journal-title":"J Clin Oncol"},{"issue":"10","key":"4268_CR58","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1038\/s41591-023-02598-9","volume":"29","author":"V Anagnostou","year":"2023","unstructured":"Anagnostou V, Ho C, Nicholas G, Juergens RA, Sacher A, Fung AS, Wheatley-Price P, Laurie SA, Levy B, Brahmer JR, Balan A, Niknafs N, Avrutin E, Zhu L, Sausen M, Bradbury PA, O\u2019Donnell-Tormey J, Gaudreau PO, Ding K, Dancey J. ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results. Nat Med. 2023;29(10):2559\u201369.","journal-title":"Nat Med"},{"issue":"s1","key":"4268_CR59","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.3233\/TUB-220044","volume":"46","author":"MJ Duffy","year":"2024","unstructured":"Duffy MJ. Circulating tumor DNA (ctDNA) as a biomarker for lung cancer: early detection, monitoring, and therapy prediction. Tumour Biol. 2024;46(s1):S283-95.","journal-title":"Tumour Biol"},{"issue":"3","key":"4268_CR60","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3390\/ijms24032505","volume":"24","author":"GMS Casagrande","year":"2023","unstructured":"Casagrande GMS, Silva MO, Reis RM, Leal LF. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs. Int J Mol Sci. 2023;24(3):2505.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4268_CR61","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/jmedgenet-2018-105825","volume":"56","author":"M Peng","year":"2019","unstructured":"Peng M, Xie Y, Li X, Qian Y, Tu X, Yao X, Cheng F, Xu F, Kong D, He B, Liu C, Cao F, Yang H, Yu F, Xu C, Tian G. Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA. J Med Genet. 2019;56(10):647\u201353.","journal-title":"J Med Genet"},{"key":"4268_CR62","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/15592294.2019.1695333","volume":"15","author":"L Vrba","year":"2020","unstructured":"Vrba L, Oshiro MM, Kim SS, Garland LL, Placencia C, Mahadevan D, et al. DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients. Epigenetics. 2020;15:419\u201330.","journal-title":"Epigenetics"},{"key":"4268_CR63","first-page":"355360","volume":"28","author":"Z Yang","year":"2019","unstructured":"Yang Z, Qi W, Sun L, Zhou H, Zhou B, Hu Y. DNA methylation analysis of selected genes for the detection of early-stage lung cancer using circulating cell-free DNA. Adv Clin Exp Med Off Organ Wroc Med Univ. 2019;28:355360.","journal-title":"Adv Clin Exp Med Off Organ Wroc Med Univ"},{"key":"4268_CR64","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, CCGA Consortium. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020;31:745\u201359.","journal-title":"Ann Oncol"},{"issue":"12","key":"4268_CR65","doi-asserted-by":"publisher","first-page":"e018884","DOI":"10.1136\/bmjopen-2017-018884","volume":"7","author":"S Leroy","year":"2017","unstructured":"Leroy S, Benzaquen J, Mazzetta A, Marchand-Adam S, Padovani B, Israel-Biet D, Pison C, Chanez P, Cadranel J, Mazi\u00e8res J, Jounieaux V, Cohen C, Hofman V, Ilie M, Hofman P, Marquette CH, AIR Project Study Group. Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France. BMJ Open. 2017;7(12):e018884.","journal-title":"BMJ Open"},{"issue":"8","key":"4268_CR66","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/JTO.0000000000000606","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen X, Zhou F, Li X, Yang G, Zhang L, Ren S, et al. Folate receptor-positive circulating tumor cell detected by LT-PCR-based method as a diagnostic biomarker for non-small-cell lung cancer. J Thorac Oncol. 2015;10(8):1163\u201371.","journal-title":"J Thorac Oncol"},{"issue":"17","key":"4268_CR67","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1158\/1078-0432.CCR-17-0577","volume":"23","author":"X Jin","year":"2017","unstructured":"Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, et al. Evaluation of tumor-derived Exosomal miRNA as potential diagnostic biomarkers for early-stage non-small cell lung Cancer using next-generation sequencing. Clin Cancer Res. 2017;23(17):5311\u20139.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4268_CR68","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1038\/s41467-021-24994-w","volume":"12","author":"D Mathios","year":"2021","unstructured":"Mathios D, Johansen JS, Cristiano S, et al. Detection and characterization of lung cancer using cell-free DNA fragmentomes. Nat Commun. 2021;12(1):5060.","journal-title":"Nat Commun"},{"key":"4268_CR69","doi-asserted-by":"publisher","unstructured":"Freitas AJA, Causin RL, Varuzza MB, et al. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer. Int J Mol Sci. 2022;23(17):9952. https:\/\/doi.org\/10.3390\/ijms23179952.","DOI":"10.3390\/ijms23179952"},{"issue":"1","key":"4268_CR70","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","volume":"6","author":"D Lin","year":"2021","unstructured":"Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, Zhu F, Zhou D, Zheng S, Chen Y, Zhou J. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther. 2021;6(1):404.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4268_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1085-0","volume":"19","author":"X Li","year":"2020","unstructured":"Li X, Li C, Zhang L, Wu M, Cao K, Jiang F, Chen D, Li N, Li W. The significance of exosomes in the development and treatment of hepatocellular carcinoma. Mol Cancer. 2020;19(1):1.","journal-title":"Mol Cancer"},{"key":"4268_CR72","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41586-020-2140-0","volume":"580","author":"JJ Chabon","year":"2020","unstructured":"Chabon JJ, et al. Integrating genomic features for noninvasive early lung cancer detection. Nature. 2020;580:245\u201351.","journal-title":"Nature"},{"key":"4268_CR73","doi-asserted-by":"publisher","unstructured":"Ren D, Li B, Chen S, Zhao Q, Zhang X, zhao H, xue W, li W, Duan G, Xu S, et al. Circulating tumor cells combined with artificial intelligence to establish a model for diagnosing the malignancy of pulmonary nodules[J]. crossref; 2024. https:\/\/doi.org\/10.21203\/rs.3.rs-3966488\/v1.","DOI":"10.21203\/rs.3.rs-3966488\/v1"},{"issue":"24","key":"4268_CR74","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.21037\/atm-22-5668","volume":"10","author":"M Ma","year":"2022","unstructured":"Ma M, Xu S, Han B, He H, Ma X, Chen C. A retrospective diagnostic test study on circulating tumor cells and artificial intelligence imaging in patients with lung adenocarcinoma. Ann Transl Med. 2022;10(24):1339.","journal-title":"Ann Transl Med"},{"key":"4268_CR75","doi-asserted-by":"publisher","unstructured":"Jin Y, et al. Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG). EClinicalMedicine. 2024;75:102769. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102769.","DOI":"10.1016\/j.eclinm.2024.102769"},{"key":"4268_CR76","doi-asserted-by":"publisher","first-page":"14797","DOI":"10.1038\/s41598-024-63411-2","volume":"14","author":"M Kim","year":"2024","unstructured":"Kim M, Park J, et al. Deep learning model integrating cfDNA methylation and fragment size profiles for lung cancer diagnosis. Sci Rep. 2024;14:14797.","journal-title":"Sci Rep"},{"key":"4268_CR77","doi-asserted-by":"publisher","first-page":"30969","DOI":"10.1038\/s41598-025-15273-5","volume":"15","author":"L Ke","year":"2025","unstructured":"Ke L, Huang X, Liu W, et al. A prediction model based on cfDNA concentration and cfDNA methylation biomarkers for lung cancer detection. Sci Rep. 2025;15:30969.","journal-title":"Sci Rep"},{"key":"4268_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101548","author":"L Li","year":"2025","unstructured":"Li L, Fu K, Cai X, et al. Diagnosis of early-stage non-small cell lung cancer using DNA methylation in tissue and plasma. Genes & Diseases. 2025. https:\/\/doi.org\/10.1016\/j.gendis.2025.101548.","journal-title":"Genes & Diseases"},{"key":"4268_CR79","doi-asserted-by":"publisher","first-page":"240","DOI":"10.6004\/jnccn.2012.0022","volume":"10","author":"DE Wood","year":"2012","unstructured":"Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl Compr Canc Netw. 2012;10:240\u201365.","journal-title":"J Natl Compr Canc Netw"},{"key":"4268_CR80","doi-asserted-by":"publisher","first-page":"j347","DOI":"10.1136\/bmj.j347","volume":"356","author":"C Rampinelli","year":"2017","unstructured":"Rampinelli C, De Marco P, Origgi D, et al. Exposure to low-dose computed tomography for Lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ. 2017;356:j347.","journal-title":"BMJ"},{"key":"4268_CR81","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.pec.2017.02.024","volume":"100","author":"CE Dunn","year":"2017","unstructured":"Dunn CE, Edwards A, Carter B, et al. The role of screening expectations in modifying short-term psychological responses to low-dose computed tomography Lung cancer screening among high-risk individuals. Patient Educ Couns. 2017;100:1572\u20139.","journal-title":"Patient Educ Couns"},{"issue":"4","key":"4268_CR82","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.athoracsur.2021.04.047","volume":"113","author":"JI Monu","year":"2022","unstructured":"Monu JI, Achar C, Wood DE, Flum DR, Agrawal N, Farjah F. Psychological traits and the persuasiveness of lung cancer screening health messages. Ann Thorac Surg. 2022;113(4):1341\u20137.","journal-title":"Ann Thorac Surg"},{"key":"4268_CR83","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12916-022-02681-x","volume":"20","author":"H Shen","year":"2022","unstructured":"Shen H, Jin Y, Zhao H, et al. Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer. BMC Med. 2022;20:480.","journal-title":"BMC Med"},{"key":"4268_CR84","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S2213-2600(20)30081-3","volume":"8","author":"CH Marquette","year":"2020","unstructured":"Marquette CH, Boutros J, Benzaquen J, et al. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study. Lancet Respir Med. 2020;8:709\u201316.","journal-title":"Lancet Respir Med"},{"key":"4268_CR85","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jare.2020.11.009","volume":"30","author":"SH Wu","year":"2020","unstructured":"Wu SH, Hsieh CC, Hsu SC, Yao M, Hsiao JK, Wang SW, Lin CP, Huang DM. RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy. J Adv Res. 2020;30:185\u201396.","journal-title":"J Adv Res"},{"key":"4268_CR86","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.semcancer.2023.01.006","volume":"89","author":"S Huang","year":"2023","unstructured":"Huang S, Yang J, Shen N, Xu Q, Zhao Q. Artificial intelligence in lung cancer diagnosis and prognosis: current application and future perspective. Semin Cancer Biol. 2023;89:30\u20137.","journal-title":"Semin Cancer Biol"},{"issue":"20","key":"4268_CR87","first-page":"1071","volume":"48","author":"X Li","year":"2021","unstructured":"Li X, Zhou Q, Tang X. Research progress of circulating tumor cells for precision medicine in lung cancer. Chin J Clin Oncol. 2021;48(20):1071\u20134.","journal-title":"Chin J Clin Oncol"},{"key":"4268_CR88","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/clinchem\/hvaa283","volume":"67","author":"Y Han","year":"2021","unstructured":"Han Y, et al. Enhanced detection of genitourinary cancers using fragmentation and copy number profiles obtained from urinary cell-free DNA. Clin Chem. 2021;67:394\u2013403.","journal-title":"Clin Chem"},{"key":"4268_CR89","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1038\/s41467-021-23445-w","volume":"12","author":"P Peneder","year":"2021","unstructured":"Peneder P, et al. Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. Nat Commun. 2021;12:3230.","journal-title":"Nat Commun"},{"key":"4268_CR90","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12885-019-6003-8","volume":"19","author":"N Wan","year":"2019","unstructured":"Wan N, et al. Machine learning enables the detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA. BMC Cancer. 2019;19:832.","journal-title":"BMC Cancer"},{"key":"4268_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01491-8","volume":"21","author":"YV Zhitnyuk","year":"2022","unstructured":"Zhitnyuk YV, et al. Deep cfDNA fragment end profiling enables cancer detection. Mol Cancer. 2022;21:26.","journal-title":"Mol Cancer"},{"key":"4268_CR92","doi-asserted-by":"crossref","unstructured":"Liu L, et al. Early cancer detection from genome-wide cell-free DNA fragmentation via the shuffled frog leaping algorithm and support vector machine. Volume 37. Bioinformatics; 2021. pp. 3099\u2013105.","DOI":"10.1093\/bioinformatics\/btab236"},{"key":"4268_CR93","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12916-021-02109-y","volume":"19","author":"G Qiao","year":"2021","unstructured":"Qiao G, et al. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study. BMC Med. 2021;19:243.","journal-title":"BMC Med"},{"key":"4268_CR94","doi-asserted-by":"crossref","unstructured":"Cao F et al. Integrated epigenetic biomarkers in circulating cell-free DNA as a robust classifier for pancreatic cancer. Clin Epigenetics. 2020;12;112.","DOI":"10.1186\/s13148-020-00898-2"},{"key":"4268_CR95","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/clinchem\/48.3.421","volume":"48","author":"YY Lui","year":"2002","unstructured":"Lui YY, et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem. 2002;48:421\u20137.","journal-title":"Clin Chem"},{"key":"4268_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.596078","volume":"11","author":"S Li","year":"2020","unstructured":"Li S, et al. Genome-wide analysis of cell-free DNA methylation profiling for the early diagnosis of pancreatic cancer. Front Genet. 2020;11:596078.","journal-title":"Front Genet"},{"key":"4268_CR97","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41523-021-00237-5","volume":"7","author":"X Yang","year":"2012","unstructured":"Yang X, et al. Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer. NPJ Breast Cancer. 2012;7:35.","journal-title":"NPJ Breast Cancer"},{"key":"4268_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00735-4","volume":"12","author":"L Raman","year":"2020","unstructured":"Raman L, et al. Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma. Genome Med. 2020;12:35.","journal-title":"Genome Med"},{"key":"4268_CR99","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/clinchem\/hvab268","volume":"68","author":"K Zhou","year":"2022","unstructured":"Zhou K, et al. Next-generation sequencing-based analysis of urine cell-free mtDNA reveals aberrant fragmentation and mutation profile in cancer patients. Clin Chem. 2022;68:561\u201373.","journal-title":"Clin Chem"},{"key":"4268_CR100","doi-asserted-by":"publisher","first-page":"eaat4921","DOI":"10.1126\/scitranslmed.aat4921","volume":"10","author":"F Mouliere","year":"2018","unstructured":"Mouliere F, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. 2018;10:eaat4921.","journal-title":"Sci Transl Med"},{"key":"4268_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081820","volume":"9","author":"M Sprang","year":"2020","unstructured":"Sprang M, Paret C, Faber J. CpG-Islands as Markers for Liquid Biopsies of Cancer Patients. Cells. 2020;9(8):1820.","journal-title":"Cells"},{"key":"4268_CR102","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1373\/clinchem.2019.309633","volume":"66","author":"G Ge","year":"2020","unstructured":"Ge G, et al. Urothelial carcinoma detection based on copy number profiles of urinary cell-free DNA by shallow whole-genome sequencing. Clin Chem. 2020;66:188\u201398.","journal-title":"Clin Chem"},{"key":"4268_CR103","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/s41591-020-0932-2","volume":"26","author":"F Nassiri","year":"2020","unstructured":"Nassiri F, et al. Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes. Nat Med. 2020;26:1044\u20137.","journal-title":"Nat Med"},{"key":"4268_CR104","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/cancers13040728","volume":"13","author":"M Panagopoulou","year":"2021","unstructured":"Panagopoulou M, et al. Circulating cell-free DNA in breast cancer: searching for hidden information towards precision medicine. Cancers (Basel). 2021;13:728.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"4268_CR105","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tig.2023.01.004","volume":"39","author":"T Moser","year":"2023","unstructured":"Moser T, K\u00fchberger S, Lazzeri I, Vlachos G, Heitzer E. Bridging biological cfDNA features and machine learning approaches. Trends Genet. 2023;39(4):285\u2013307.","journal-title":"Trends Genet"},{"key":"4268_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55594-z","author":"M Zhao","year":"2025","unstructured":"Zhao M, et al. Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer. Nat Commun. 2025. https:\/\/doi.org\/10.1038\/s41467-024-55594-z.","journal-title":"Nat Commun"},{"key":"4268_CR107","doi-asserted-by":"publisher","first-page":"100599","DOI":"10.1016\/j.clinsp.2025.100599","volume":"80","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. Multi-omics model is an effective means to diagnose benign and malignant pulmonary nodules. Clin (Sao Paulo). 2025;80:100599.","journal-title":"Clin (Sao Paulo)"},{"key":"4268_CR108","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-2025-317","author":"B Wei","year":"2025","unstructured":"Wei B, et al. An effective and affordable blood test for lung cancer early detection using four protein markers and artificial intelligence. Transl Lung Cancer Res. 2025. https:\/\/doi.org\/10.21037\/tlcr-2025-317.","journal-title":"Transl Lung Cancer Res"},{"issue":"120","key":"4268_CR109","first-page":"121","volume":"22","author":"ZB Xie","year":"2016","unstructured":"Xie ZB, Yao L, Jin C, Fu DL. Circulating tumor cells in pancreatic cancer patients: efficacy in diagnosis and value in prognosis. Discov Med. 2016;22(120):121\u20138.","journal-title":"Discov Med"},{"key":"4268_CR110","doi-asserted-by":"crossref","unstructured":"Miller MC, Doyle GV, Terstappen LW. Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients With Metastatic Breast, Colorectal, and Prostate Cancer. J Oncol. 2010;2010:617421.","DOI":"10.1155\/2010\/617421"},{"key":"4268_CR111","doi-asserted-by":"crossref","unstructured":"Cubero MA, Lorente J, Robles-Fernandez I, Rodriguez-Martinez A, Puche J, Serrano M. Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection. In: Circulating Tumor Cells. New York: Springer; 2017. p. 283\u2013303.","DOI":"10.1007\/978-1-4939-7144-2_24"},{"key":"4268_CR112","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/mi12111349","volume":"12","author":"S Akg\u00f6n\u00fcll\u00fc","year":"2021","unstructured":"Akg\u00f6n\u00fcll\u00fc S, Bakhshpour M, Pi\u015fkin AK, et al. Microfluidic systems for cancer diagnosis and Applications. Micromachines. 2021;12:1349.","journal-title":"Micromachines"},{"issue":"1","key":"4268_CR113","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13045-022-01280-w","volume":"15","author":"Y Han","year":"2022","unstructured":"Han Y, Wang D, Peng L, Huang T, He X, Wang J, Ou C. Single-cell sequencing: a promising approach for uncovering the mechanisms of tumor metastasis. J Hematol Oncol. 2022;15(1):59.","journal-title":"J Hematol Oncol"},{"issue":"SUP11","key":"4268_CR114","first-page":"76","volume":"26","author":"Y Wei-Lei","year":"2020","unstructured":"Wei-Lei Y, Chi-Bin L, Jia-Yang C, Samuel C, Ten-Jen L, Ying-Chih C, et al. Artificial intelligence assists automation and high performance of circulating tumor cells enumeration and circulating tumor microemboli characterization in fluorescence microscopy images[J]. Clin Cancer Res. 2020;26(SUP11):76\u20137.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4268_CR115","doi-asserted-by":"publisher","first-page":"7744","DOI":"10.1021\/acsnano.1c01741","volume":"15","author":"Y Reef Einoch-Amor, Yoav","year":"2021","unstructured":"Reef Einoch-Amor, Yoav Y, Broza H, Haick. Detection Of Single Cancer Cells In Blood With Artificially Intelligent Nanoarray[J]. ACS Nano. 2021;15(4):7744\u201355.","journal-title":"ACS Nano"},{"key":"4268_CR116","doi-asserted-by":"publisher","first-page":"856575","DOI":"10.3389\/fonc.2022.856575","volume":"12","author":"O Ginghina","year":"2022","unstructured":"Ginghina O, Hudita A, Zamfir M, Spanu A, Mardare M, Bondoc I, Buburuzan L, Georgescu SE, Costache M, Negrei C, Nitipir C, Galateanu B. Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient\u2019s Stratification. Front Oncol. 2022;12:856575.","journal-title":"Front Oncol"},{"issue":"4","key":"4268_CR117","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180322","volume":"38","author":"Y-C Yang","year":"2018","unstructured":"Yang Y-C, Wang D, Jin L, Yao H-W, Zhang J-H, Wang J, et al. Circulating tumor DNA detectable in early-and late-stage colorectal cancer patients. Biosci Rep. 2018;38(4):BSR20180322.","journal-title":"Biosci Rep"},{"issue":"12","key":"4268_CR118","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/1078-0432.CCR-15-0297","volume":"22","author":"S El Messaoudi","year":"2016","unstructured":"El Messaoudi S, Mouliere F, Du Manoir S, Bascoul-Mollevi C, Gillet B, Nouaille M, et al. Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care. Clin Cancer Res. 2016;22(12):3067\u201377.","journal-title":"Clin Cancer Res"},{"key":"4268_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194743","volume":"13","author":"E Moati","year":"2021","unstructured":"Moati E, Taly V, Garinet S, et al. Role of circulating tumor DNA in gastrointestinal cancers: current knowledge and perspectives. Cancers. 2021;13:4743.","journal-title":"Cancers"},{"key":"4268_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.bdq.2019.100087","volume":"17","author":"AJ Bronkhorst","year":"2019","unstructured":"Bronkhorst AJ, Ungerer V, Holdenrieder S. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif. 2019;17:100087.","journal-title":"Biomol Detect Quantif"},{"key":"4268_CR121","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/511524a","volume":"511","author":"E Yong","year":"2014","unstructured":"Yong E. Cancer biomarkers: written in blood. Our Nat. 2014;511:524\u20136.","journal-title":"Our Nat"},{"issue":"8","key":"4268_CR122","doi-asserted-by":"publisher","first-page":"e0183915","DOI":"10.1371\/journal.pone.0183915","volume":"12","author":"MR Fernando","year":"2017","unstructured":"Fernando MR, Jiang C, Krzyzanowski GD, Ryan WL. New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS One. 2017;12(8):e0183915.","journal-title":"PLoS One"},{"key":"4268_CR123","first-page":"1","volume":"1740","author":"N Sadik","year":"2018","unstructured":"Sadik N, Cruz L, Gurtner A, Rodosthenous RS, Dusoswa SA, Ziegler O, et al. Extracellular RNAs: a new awareness of old perspectives. Extracell RNA Methods Protocols. 2018;1740:1\u201315.","journal-title":"Extracell RNA Methods Protocols"},{"key":"4268_CR124","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3389\/fgene.2019.00626","volume":"10","author":"MY Cui","year":"2019","unstructured":"Cui MY, Wang HD, Yao XX, Zhang D, Xie YJ, Cui RJ, et al. Circulating microRNAs in Cancer: potential and challenge. Front Genet. 2019;10:626.","journal-title":"Front Genet"},{"key":"4268_CR125","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, et al. Liquid biopsies come of age: towards implementation of circulating tumor DNA. Nat Rev Cancer. 2017;17:223\u201338.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"4268_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218062","volume":"21","author":"S Grabuschnig","year":"2020","unstructured":"Grabuschnig S, Bronkhorst AJ, Holdenrieder S, Rodriguez IR, Schliep KP, Schwendenwein D, et al. Putative origins of cell-free DNA in humans: a review of active and passive nucleic acid release mechanisms. Int J Mol Sci. 2020;21(21):8062.","journal-title":"Int J Mol Sci"},{"key":"4268_CR127","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1093\/nar\/gkr254","volume":"39","author":"A Turchinovich","year":"2011","unstructured":"Turchinovich A, Weiz L, Langheinz A, Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39:7223\u201333.","journal-title":"Nucleic Acids Res"},{"key":"4268_CR128","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ncb2210","volume":"13","author":"KC Vickers","year":"2011","unstructured":"Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423-U182.","journal-title":"Nat Cell Biol"},{"key":"4268_CR129","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1158\/1078-0432.CCR-15-0943","volume":"22","author":"D Chu","year":"2016","unstructured":"Chu D, Paoletti C, Gersch C, et al. ESR1 mutations in circulating plasma tumor DNA from metastatic breast cancer patients. ESR1 mutations detected in circulating tumor DNA. Clin Cancer Res. 2016;22:993\u20139.","journal-title":"Clin Cancer Res"},{"key":"4268_CR130","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/ng.2823","volume":"45","author":"DR Robinson","year":"2013","unstructured":"Robinson DR, Wu YM, Vats P, et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet. 2013;45:1446\u201351.","journal-title":"Nat Genet"},{"key":"4268_CR131","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(21)00034-6","volume":"22","author":"HS Rugo","year":"2021","unstructured":"Rugo HS, Lerebours F, Ciruelos E, et al. Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4\/6 inhibitor (BYLieve): one cohort of phase 2, multicentre, open-label, non-comparative study. Lancet Oncol. 2021;22:489\u201398.","journal-title":"Lancet Oncol"},{"key":"4268_CR132","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41416-021-01601-9","volume":"126","author":"C Suppan","year":"2022","unstructured":"Suppan C, Graf R, Jahn S, et al. Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients. Br J Cancer. 2022;126:456\u201363.","journal-title":"Br J Cancer"},{"key":"4268_CR133","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1002\/adma.201305348","volume":"26","author":"B Xiong","year":"2014","unstructured":"Xiong B, Ren K, Shu Y, et al. Recent developments in microfluidics for cell studies. Adv Mater. 2014;26:5525\u201332.","journal-title":"Adv Mater"},{"key":"4268_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01481-y","volume":"20","author":"X Cao","year":"2022","unstructured":"Cao X, Ge S, Hua W, et al. A pump-free and high-throughput microfluidic chip for highly sensitive SERS assay of gastric cancer-related circulating tumor DNA via a cascade signal amplification strategy. J Nanobiotechnology. 2022;20:13.","journal-title":"J Nanobiotechnology"},{"key":"4268_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101589","volume":"27","author":"E Visser","year":"2023","unstructured":"Visser E, et al. Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer. Transl Oncol. 2023;27:101589.","journal-title":"Transl Oncol"},{"key":"4268_CR136","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.lungcan.2023.01.014","volume":"178","author":"E Visser","year":"2023","unstructured":"Visser E, et al. Liquid biopsy-based decision support algorithms for diagnosis and subtyping of lung cancer. Lung Cancer. 2023;178:28\u201336.","journal-title":"Lung Cancer"},{"key":"4268_CR137","doi-asserted-by":"crossref","unstructured":"Gregg JP, et al. Novel blood-based assay for detection of early stage multi-cancer. J Clin Oncol. 2023;41(16_suppl):e15035\u2013e15035.","DOI":"10.1200\/JCO.2023.41.16_suppl.e15035"},{"issue":"5","key":"4268_CR138","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23743","volume":"35","author":"J Xia","year":"2021","unstructured":"Xia J, Luo M, Dai L, Wang L, Wang L, Zhu J. Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer. J Clin Lab Anal. 2021;35(5):e23743.","journal-title":"J Clin Lab Anal"},{"key":"4268_CR139","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ccell.2022.10.022","volume":"40","author":"A Jamshidi","year":"2022","unstructured":"Jamshidi A, Liu MC, Klein EA, et al. Evaluation of cell-free DNA approaches for multi-cancer early detection. Cancer Cell. 2022;40:1537\u2013e15491512.","journal-title":"Cancer Cell"},{"key":"4268_CR140","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00828-2","volume":"12","author":"C Chen","year":"2020","unstructured":"Chen C, Huang X, Yin W, et al. Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules. Clin Epigenetics. 2020;12:39.","journal-title":"Clin Epigenetics"},{"key":"4268_CR141","doi-asserted-by":"crossref","unstructured":"Naixin, Liang et al. Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning. Nat Biomedical Eng. 2021;5(6):586\u201399.","DOI":"10.1038\/s41551-021-00746-5"},{"key":"4268_CR142","doi-asserted-by":"publisher","unstructured":"Bahado-Singh R, et al. Precision Oncology: Artificial Intelligence and DNA Methylation Analysis of Circulating Cell-Free DNA for Lung Cancer Detection. Front Oncol. 2022;12:790645. https:\/\/doi.org\/10.3389\/fonc.2022.790645.","DOI":"10.3389\/fonc.2022.790645"},{"issue":"15_suppl","key":"4268_CR143","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1200\/JCO.2020.38.15_suppl.1550","volume":"38","author":"H Zheng","year":"2020","unstructured":"Zheng H, et al. A noninvasive multi-analytic approach for lung cancer screening of patients with pulmonary nodules. J Clin Oncol. 2020;38(15_suppl):1550\u20131550.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4268_CR144","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41467-023-37403-1","volume":"14","author":"H Shin","year":"2023","unstructured":"Shin H, Choi BH, Shim O, Kim J, Park Y, Cho SK, Kim HK, Choi Y. Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers. Nat Commun. 2023;14(1):1644.","journal-title":"Nat Commun"},{"issue":"5","key":"4268_CR145","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1021\/acsnano.9b09119","volume":"14","author":"H Shin","year":"2020","unstructured":"Shin H, Oh S, Hong S, Kang M, Kang D, Ji YG, Choi BH, Kang KW, Jeong H, Park Y, Hong S, Kim HK, Choi Y. Early-Stage Lung Cancer Diagnosis by Deep Learning-Based Spectroscopic Analysis of Circulating Exosomes. ACS Nano. 2020;14(5):5435\u201344.","journal-title":"ACS Nano"},{"key":"4268_CR146","doi-asserted-by":"publisher","first-page":"e82669","DOI":"10.7554\/eLife.82669","volume":"11","author":"EK Ramos","year":"2022","unstructured":"Ramos EK, Tsai CF, Jia Y, Cao Y, et al. Machine learning-assisted elucidation of CD81-CD44 interactions in promoting cancer stemness and extracellular vesicle integrity. Elife. 2022;11:e82669.","journal-title":"Elife"},{"issue":"17","key":"4268_CR147","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.1021\/acs.analchem.4c00669","volume":"96","author":"M Chen","year":"2024","unstructured":"Chen M, Wang H, Zhang Y, Jiang H, Li T, Liu L, Zhao Y. Label-Free Multiplex Profiling of Exosomal Proteins with a Deep Learning-Driven 3D Surround-Enhancing SERS Platform for Early Cancer Diagnosis. Anal Chem. 2024;96(17):6794\u2013801.","journal-title":"Anal Chem"},{"issue":"3","key":"4268_CR148","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.suc.2021.12.001","volume":"102","author":"AL Oliver","year":"2022","unstructured":"Oliver AL. Lung cancer: epidemiology and screening. Surg Clin North Am. 2022;102(3):335\u201344.","journal-title":"Surg Clin North Am"},{"issue":"4","key":"4268_CR149","doi-asserted-by":"publisher","first-page":"412","DOI":"10.6004\/jnccn.2018.0020","volume":"16","author":"DE Wood","year":"2018","unstructured":"Wood DE, Kazerooni EA, Baum SL, et al. Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(4):412\u201341.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"4268_CR150","first-page":"157","volume":"51","author":"L Wei","year":"2021","unstructured":"Wei L, El Naqa I. Artificial intelligence for response evaluation with PET\/CT semin. Nucl Med. 2021;51(2):157\u201369.","journal-title":"Nucl Med"},{"key":"4268_CR151","doi-asserted-by":"publisher","first-page":"11815","DOI":"10.1038\/ncomms11815","volume":"7","author":"JJ Chabon","year":"2016","unstructured":"Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, et al. Circulating tumor DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nat Commun. 2016;7:11815.","journal-title":"Nat Commun"},{"key":"4268_CR152","doi-asserted-by":"publisher","unstructured":"Otsubo K, Sakai K, Takeshita M, et al. Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA. Oncologist. 2019;24(8):1022\u20136. https:\/\/doi.org\/10.1634\/theoncologist.2019-0101.","DOI":"10.1634\/theoncologist.2019-0101"},{"key":"4268_CR153","doi-asserted-by":"crossref","unstructured":"Celi LA, et al. Sources of bias in artificial intelligence that perpetuate healthcare disparities\u2014A global review. PLOS Digit Heal. 2022;1(3):e0000022.","DOI":"10.1371\/journal.pdig.0000022"},{"key":"4268_CR154","doi-asserted-by":"publisher","first-page":"391823","DOI":"10.1111\/cas.15052","volume":"112","author":"J Qi","year":"2021","unstructured":"Qi J, Hong B, Tao R, et al. Prediction model for malignant pulmonary nodules based on cfMeDIP-seq and machine learning. Cancer Sci. 2021;112:391823.","journal-title":"Cancer Sci"},{"key":"4268_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2021.107739","volume":"49","author":"PS Reel","year":"2021","unstructured":"Reel PS, Reel S, Pearson E, Trucco E, Jefferson E. Using machine learning approaches for multi-omics data analysis: a review. Biotechnol Adv. 2021;49:107739.","journal-title":"Biotechnol Adv"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04268-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04268-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T03:27:45Z","timestamp":1782098865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04268-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":155,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4268"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04268-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a narrative review based on previously published studies and does not involve any new studies with human participants or animals performed by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"262"}}